AllianceBernstein’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $726K | Buy |
50,350
+40,300
| +401% | +$581K | ﹤0.01% | 2457 |
|
|
2025
Q1 | $69.3K | Hold |
10,050
| – | – | ﹤0.01% | 3101 |
|
|
2024
Q4 | $53.3K | Hold |
10,050
| – | – | ﹤0.01% | 3182 |
|
|
2024
Q3 | $36.7K | Hold |
10,050
| – | – | ﹤0.01% | 3204 |
|
|
2024
Q2 | $27.4K | Buy |
+10,050
| New | +$27.4K | ﹤0.01% | 3216 |
|
|
2022
Q2 | – | Sell |
-24,100
| Closed | -$59K | – | 3393 |
|
|
2022
Q1 | $59K | Sell |
24,100
-5,200
| -18% | -$12.7K | ﹤0.01% | 3155 |
|
|
2021
Q4 | $110K | Hold |
29,300
| – | – | ﹤0.01% | 3173 |
|
|
2021
Q3 | $184K | Hold |
29,300
| – | – | ﹤0.01% | 3096 |
|
|
2021
Q2 | $289K | Buy |
29,300
+14,800
| +102% | +$146K | ﹤0.01% | 3010 |
|
|
2021
Q1 | $135K | Sell |
14,500
-29,700
| -67% | -$277K | ﹤0.01% | 3111 |
|
|
2020
Q4 | $212K | Hold |
44,200
| – | – | ﹤0.01% | 2963 |
|
|
2020
Q3 | $177K | Sell |
44,200
-2,700
| -6% | -$10.8K | ﹤0.01% | 2974 |
|
|
2020
Q2 | $215K | Buy |
46,900
+26,300
| +128% | +$121K | ﹤0.01% | 2978 |
|
|
2020
Q1 | $67K | Buy |
20,600
+9,900
| +93% | +$32.2K | ﹤0.01% | 3015 |
|
|
2019
Q4 | $46K | Hold |
10,700
| – | – | ﹤0.01% | 3089 |
|
|
2019
Q3 | $42K | Buy |
+10,700
| New | +$42K | ﹤0.01% | 3121 |
|